1. Kim E, Lauterbach EC, Reeve A, Arciniegas DB, Coburn KL, Mendez MF, et al. Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research). J Neuropsychiatry Clin Neurosci. 2007; 19:106–127. PMID:
17431056.
2. Zhao Q, Xie C, Pesco-Koplowitz L, Jia X, Parier JL. Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil. J Clin Pharmacol. 2003; 43:180–186. PMID:
12616671.
Article
3. Reyes JF, Preskorn SH, Khan A, Kumar D, Cullen EI, Perdomo CA, et al. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses. Br J Clin Pharmacol. 2004; 58(Suppl 1):50–57. PMID:
15496223.
Article
4. Brown CS, Markowitz JS, Moore TR, Parker NG. Atypical antipsychotics. Part II: Adverse effects, drug interactions, and costs. Ann Pharmacother. 1999; 33:210–217. PMID:
10084417.
Article
5. Daiello LA. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Med Health R I. 2007; 90:191–194. PMID:
17633594.
6. Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, et al. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biol Pharm Bull. 2009; 32:318–324. PMID:
19252271.
Article
7. Maany I. Adverse interaction of tacrine and haloperidol. Am J Psychiatry. 1996; 153:1504. PMID:
8890692.
8. McSwain ML, Forman LM. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. J Clin Psychopharmacol. 1995; 15:284. PMID:
7593712.
Article
9. Arai M. Parkinsonism onset in a patient concurrently using tiapride and donepezil. Intern Med. 2000; 39:863. PMID:
11030219.
Article
10. Liu HC, Lin SK, Sung SM. Extrapyramidal side-effect due to drug combination of risperidone and donepezil. Psychiatry Clin Neurosci. 2002; 56:479. PMID:
12109969.
Article